Skip to content
10-Q

Quarterly Report

SKINOVATION PHARMACEUTICAL INCORPORATED

0001554795-24-000123

← back to feed
Filed
May 9, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 6, 2024 708K sh
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$3.5K
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$4.22K
Cash And Equivalents Q1 2024 · Mar 31, 2024 $12.73K
Cash And Equivalents Q1 2024 · Dec 31, 2023 $16.23K
Stockholders Equity Q1 2024 · Mar 31, 2024 −$462.97K
Stockholders Equity Q1 2024 · Dec 31, 2023 −$447.2K
Stockholders Equity Q1 2024 · Mar 31, 2023 −$422.12K
Stockholders Equity Q1 2024 · Dec 31, 2022 −$411.34K
Current Liabilities Q1 2024 · Mar 31, 2024 $475.71K
Current Liabilities Q1 2024 · Dec 31, 2023 $463.44K
Total Liabilities Q1 2024 · Mar 31, 2024 $475.71K
Total Liabilities Q1 2024 · Dec 31, 2023 $463.44K
Current Assets Q1 2024 · Mar 31, 2024 $12.73K
Current Assets Q1 2024 · Dec 31, 2023 $16.23K
Total Assets Q1 2024 · Mar 31, 2024 $12.73K
Total Assets Q1 2024 · Dec 31, 2023 $16.23K
Sga Expense Q1 2024 · Mar 31, 2024 $10.05K
Sga Expense Q1 2024 · Mar 31, 2023 $5.72K
Net Income Q1 2024 · Mar 31, 2024 −$15.77K
Net Income Q1 2024 · Mar 31, 2023 −$10.78K
Operating Income Q1 2024 · Mar 31, 2024 −$10.05K
Operating Income Q1 2024 · Mar 31, 2023 −$5.72K